Scott Jordan is a FINRA licensed registered representative with over 30 years of experience in the life sciences industry as a C-Level / business development executive and investment banker. During this time, Scott successfully assisted biotechnology companies raise private placements / secondary public stock offerings, securing regional/global licensing agreements, and facilitating liquidity events via M&A,… Continue reading Scott Jordan

Chris Lehman is a seasoned financial and business development leader in the life sciences industry with an exceptional combination of strategic partnering & financial leadership experience; 25+ years with venture-backed private and public industry leaders in therapeutics, diagnostics, CRO and industrial biotech. Led or supported 30+ partnering and financing transactions totaling $2 billion with $1… Continue reading Chris Lehman CFO

William was a former Director at Sorrento Therapeutics with several decades of hands-on experience in cellular/molecular immunology, bioanalytical and assay development under cGMP compliance. His industrial experience spans several companies such as The Immune Corporation, Tragen Pharmaceuticals, Genoptix Inc., Telos Pharmaceuticals LLC., Microislet Inc., Scantibodies Laboratories and Gilead Sciences Inc. He has a proven track… Continue reading William Soo Hoo PhD

Bret is a seasoned finance professional with 30 years of accounting and finance experience. He is a CPA licensed to practice by the state of California and has an MS in Taxation from SDSU and a BS in Business Administration from UC Riverside. He has previously worked with firms such as Randstad USA, TIBCO Software, BT… Continue reading Bret McMillan

Chaozhong has extensive experience in cell-related product development such as immortalized cell lines, stable reporter cell lines, and cell-based assays development. He is currently the CTO of Cell Therapy at Simnova Biotherapeutics. Prior to that he was the VP of Product Development, Cell Therapy at Wugen and Head, Vector Cell Bank and Analytics at Takeda.… Continue reading Chaozhong Zou Ph.D.

Dr. Jakubowski came to TargaZyme after a long career in both big and small pharmaceutical.  She started her career at Bristol Myers, working with dermatological products and then moving to the Bristol Myers Research Center in Wallingford, CT, where she built and led a regulatory group that focused on building a single, international dossier that… Continue reading Audrey Jakuwboski, PhD

Dr. Srivastava is a Clinician-Scientist and a global leader in cancer drug development and an executive leader who has managed global clinical trials with multi-million-dollar budgets and has mediated the merger and acquisition of several pharma companies. He has led more than 150 global phase 1-4 clinical trials involving several cancers and as an oncologist,… Continue reading Ashok Srivastava, MD, PhD, MBA

Mr. Ma leads our international business development initiatives, leveraging his expertise in investment banking and M&A transactions. Prior to joining Targazyme, he was an investment banker responsible for M&A and licensing transactions at Suntrust Robinson Humphrey, Aaron-Bell International and Evergreen Advisors. Mr. Ma graduated from the United States Military Academy at Westpoint with a Bachelor… Continue reading Philip Ma, MBA

Dr. Jung is a biostatistician with a balanced experience in collaboration with cancer investigators and methodological research. He has been collaborating on cancer studies for over 30 years in the cooperative cancer trial group setting (NCCTG, ACOSOG, CALGB, Alliance) as well as within an NCI – designated cancer center setting (Mayo Cancer Center, Indiana University… Continue reading Sin-Ho Jung, PhD